Although we again observed that CD4+ T cells were not required to generate ZIKV-specific IgM Abs, there was a marked reduction in neutralizing activity in the sera from anti-CD4 Ab-treated compared with control mice, consistent with production of IgG neutralizing Abs at this later time point during the primary infection (S3C Fig). The gene discussed is DDX41; the disease is infection.